A Patient-reported Outcome Measure for Effect of Glucocorticoid Therapy in Adults with Inflammatory Diseases Is Needed: Report from the OMERACT 2016 Special Interest Group
Rachel Black(The University of Sydney), Catherine Hill(Royal Adelaide Hospital), Susan M. Goodman(Hospital for Special Surgery), Eileen Harrison(Norfolk and Norwich University Hospital), Joanna Robson(University of the West of England), Lana Yin Hui Lai(University of Manchester), P. Scott Richards(University of Minnesota Morris), Lorna Neill(Norfolk and Norwich University Hospital), Lee S. Simon(Norfolk and Norwich University Hospital), Sarah Mackie(Leeds Teaching Hospitals NHS Trust), Elizabeth Hoon(University of the West of England), J. Michael Nebesky(University of the West of England), Linda Nelsen(University of the West of England)
Cited by 22
Related Papers
Defining inflammatory cell states in rheumatoid arthritis joint synovial tissues by integrating single-cell transcriptomics and mass cytometry
|Nature Immunology|2019|1.4k
Global, regional, and national burden of rheumatoid arthritis, 1990–2020, and projections to 2050: a systematic analysis of the Global Burden of Disease Study 2021
|The Lancet Rheumatology|2023|584
Prevalence, Deaths, and Disability‐Adjusted Life Years Due to Musculoskeletal Disorders for 195 Countries and Territories 1990–2017
|Arthritis & Rheumatology|2020|395